k.chukwu

TL2 Moderator · Ghent

Contributes reviews on supplier material. Based in Ghent.

Joined 10 August 2025 · last posted 4d

78 posts, newest first. Showing up to 150.

Sleep apnoea improving and the equipment implications Replied, post #18 · Wellbeing › Sleep · 24 Jul 2026 · 1 like Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
Insurance and replacement policies, compared Replied, post #113 · Sourcing › Logistics · 24 Jul 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #56 · Pharmacology › Pharmacokinetics · 20 Jul 2026 · 0 likes Worth separating two things that post #52 runs together. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #76 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Alcohol: what is documented and what is folklore Replied, post #111 · Practice › Interactions · 14 Jul 2026 · 1 like Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
Athletes in weight-category sports: a different risk calculus Replied, post #24 · Clinical › Special populations · 13 Jul 2026 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #56 · Access › Insurance & coverage · 5 Jul 2026 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Comparing prices across jurisdictions without misleading yourself Replied, post #9 · Access › Pricing · 27 May 2026 · 5 likes Coming back to post #7, because the follow-up matters more than the original answer. Compute cost per delivered dose at your dose if you want a number you can act on.…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #23 · Compounds › Semaglutide · 24 May 2026 · 30 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #38 · Practice › Dosing & titration · 20 May 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Batch numbers that do not match the vial label Replied, post #12 · Sourcing › Red flags · 3 May 2026 · 26 likes I read post #10 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
A plateau that disappeared when I changed how I measured — the long version Replied, post #32 · Outcomes › Progress reports · 29 Apr 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A site rotation scheme that is easy enough to actually follow Replied, post #50 · Practice › Administration · 27 Apr 2026 · 17 likes Coming back to post #48, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
Fatigue in the first month: how much is the drug and how much is intake Started this topic · Practice › Side effects · 16 Apr 2026 · 0 likes On the subject in the title: Fatigue in the first month: how much is the drug and how much is intake Working notes rather than a conclusion. A question about technique…
About the UK & Ireland category Replied, post #8 · Regional › UK & Ireland · 16 Apr 2026 · 0 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
Type 2 diabetes and the largest part of the evidence base Replied, post #63 · Clinical › Comorbidities · 11 Apr 2026 · 6 likes post #62 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Spike-and-recover accuracy for a peptide assay Replied, post #77 · Analytics › Method validation · 9 Apr 2026 · 2 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Run-in periods and the population they select Replied, post #94 · Evidence › Trials · 5 Apr 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #13 · Evidence › Journal club · 21 Mar 2026 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
EU-wide position versus national implementation — what changed since Replied, post #20 · Regional › European Union · 19 Mar 2026 · 28 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
[2026 update] Composite endpoints and the component doing the work Replied, post #35 · Evidence › Trials · 18 Mar 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #12 · Evidence › Journal club · 7 Mar 2026 · 3 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Contributing data without breaching anyone's privacy Replied, post #20 · Data & Tools › Datasets · 3 Mar 2026 · 27 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #12 · Compounds › Repair & healing peptides · 22 Feb 2026 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
A calculator that gives a right answer to the wrong question Replied, post #6 · Data & Tools › Calculators · 19 Feb 2026 · 17 likes On post #2 — agreed on the reasoning, with one qualification. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired.…
Mass error in ppm: the arithmetic and the caveat Started this topic · Analytics › Mass spectrometry · 11 Feb 2026 · 17 likes Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #14 · Evidence › Study critique · 30 Jan 2026 · 0 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
Coming back to: Training through a dose escalation week Replied, post #13 · Nutrition & Training › Resistance training · 22 Jan 2026 · 22 likes I read post #11 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Tracking a preprint to publication: a worked example Replied, post #28 · Evidence › Preprints · 2 Dec 2025 · 24 likes This follows post #25 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #27 · Practice › Side effects · 16 Nov 2025 · 28 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #91 · Evidence › Journal club · 11 Nov 2025 · 17 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Why the titration planner refuses to produce a schedule below a floor Replied, post #9 · marked as the solution · Data & Tools › Calculators · 11 Nov 2025 · 13 likes This follows post #6 rather than contradicting it. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #27 · Compounds › Oral incretins · 2 Nov 2025 · 1 like Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Availability by country, dated, with primary sources Replied, post #29 · Access › International · 22 Oct 2025 · 3 likes post #28 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
Where to report an adverse event officially, by region — a second dataset Replied, post #41 · Safety › Adverse events · 21 Oct 2025 · 0 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
Cross-border purchase rules within the EU Replied, post #26 · Regional › European Union · 19 Oct 2025 · 29 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #120 · Compounds › Retatrutide · 1 Oct 2025 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #72 · Evidence › Journal club · 29 Sep 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Request: a diff view for wiki revisions — the long version Replied, post #47 · Meta › Feature requests · 25 Sep 2025 · 0 likes This follows post #44 rather than contradicting it. Community support: if other people support your request, they can reply with "+1" or "I would use that too".…
Hepatic impairment and the absence of data Replied, post #26 · Clinical › Special populations · 3 Sep 2025 · 15 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
Confounding by indication, explained with a concrete example Replied, post #24 · Evidence › Study critique · 3 Sep 2025 · 21 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #99 · Access › Insurance & coverage · 30 Aug 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Angle of injection and whether 90 degrees is always right Replied, post #13 · Practice › Administration · 21 Aug 2025 · 13 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
Revisiting: German, French and Dutch differences, compared Replied, post #59 · Regional › European Union · 16 Aug 2025 · 9 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
Pinch or no pinch, and how needle length changes the answer Replied, post #14 · Practice › Administration · 9 Aug 2025 · 4 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
A ten-fold dose error caught before injection — one year on Replied, post #105 · Devices › Syringes & needles · 4 Aug 2025 · 4 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
Managing an unplanned gap in supply — what changed since Replied, post #28 · Access › Shortages · 31 Jul 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Criticising the method without criticising the authors — one year on Replied, post #11 · Evidence › Study critique · 13 Jul 2025 · 0 likes On post #7 — agreed on the reasoning, with one qualification. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #4 · Compounds › Retatrutide · 6 Jul 2025 · 23 likes I read post #3 twice before replying, because I had assumed the opposite. Dose escalation in the published trials: the protocols started at lower doses and escalated by…
Lyophilisation and why the cake looks the way it does Replied, post #7 · Pharmacology › Formulation chemistry · 5 Jul 2025 · 22 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
Micronutrient status when intake falls substantially Replied, post #12 · Clinical › Bloodwork · 21 Jun 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #23 · Clinical › Special populations · 13 Jun 2025 · 0 likes post #22 answers the question as asked. The question underneath it is different. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #133 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 0 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
Coming back to: Getting a referral rather than a refusal Replied, post #11 · Clinical › Prescriber conversations · 28 May 2025 · 2 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
Coming back to: An 18-month record including the parts that went badly Replied, post #49 · Outcomes › Progress reports · 8 May 2025 · 22 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
When "no data" is the complete and final answer Replied, post #159 · Compounds › Other compounds · 25 Apr 2025 · 17 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
Deamidation and the close-eluting pair it produces Replied, post #30 · Analytics › Impurities & related substances · 22 Apr 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #130 · Compounds › Semaglutide · 3 Apr 2025 · 8 likes post #129 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
A promotion I argued against, and why I lost Replied, post #152 · Documentation › Doc review · 29 Mar 2025 · 5 likes Coming back to post #150, because the follow-up matters more than the original answer. New maintainer recruitment: if a page's maintainer is inactive and updates are…
Units, standards, and other things that quietly hold the world together Replied, post #6 · Lounge › Off topic · 26 Mar 2025 · 4 likes This follows post #3 rather than contradicting it. Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta)…
Asking about a compound your prescriber has not heard of Replied, post #5 · Clinical › Prescriber conversations · 25 Mar 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Clarifying indication: if a compound is approved for diabetes but you have obesity without…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #91 · Pharmacology › Receptor biology · 13 Mar 2025 · 23 likes I read post #89 twice before replying, because I had assumed the opposite. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and…
Over-dilution: when your dose falls below one readable graduation Replied, post #16 · Practice › Reconstitution · 6 Mar 2025 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
What we do not know about retatrutide, listed explicitly Replied, post #109 · Compounds › Retatrutide · 24 Feb 2025 · 0 likes Picking up post #106: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Journal club: SURMOUNT-1, read without the press release Replied, post #59 · Evidence › Journal club · 11 Feb 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Escalating every six weeks instead of four: what I observed over eight months Replied, post #2 · Practice › Dosing & titration · 30 Dec 2024 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #79 · Compounds › Tirzepatide · 9 Dec 2024 · 2 likes This follows post #76 rather than contradicting it. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady…
Washout with a one-week half-life: the arithmetic Replied, post #17 · Research Methods › N-of-1 designs · 25 Nov 2024 · 1 like post #16 is right about the mechanism and I think understates the practical bit. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
Two sessions a week versus four: what the evidence supports Replied, post #2 · Nutrition & Training › Resistance training · 10 Nov 2024 · 25 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
Time to steady state after a dose increase Replied, post #5 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 26 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #45 · Clinical › Comorbidities · 16 Oct 2024 · 3 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #7 · Sourcing › Regulatory · 4 Oct 2024 · 10 likes This follows post #4 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
The C-cell question: rodent findings and their human context — what changed since Replied, post #62 · Compounds › Semaglutide · 20 Sep 2024 · 10 likes This follows post #59 rather than contradicting it. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved…
Why a preprint's supplementary material is often the best part Replied, post #9 · Evidence › Preprints · 1 Sep 2024 · 28 likes Worth separating two things that post #5 runs together. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #61 · Nutrition & Training › Hydration & electrolytes · 27 Aug 2024 · 0 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
The mass-error checker and its intended scope Replied, post #87 · Data & Tools › Calculators · 30 Jun 2024 · 8 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #2 · Nutrition & Training › Resistance training · 29 May 2024 · 0 likes This follows the opening post rather than contradicting it. Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance…
Assessing a warm arrival: the decision process — one year on Replied, post #4 · Sourcing › Logistics · 28 May 2024 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…